How to protect COVID-19 patients against ventilator? Surprising treatment comes to light

According to Baaghi TV reports, many countries across the globe are currently experiencing the second and third wave of COVID-19, following its outbreak from China’s Wuhan region in late 2019. 

Govt provides best services at COVID-19 vaccination centers: Dr. Faisal

Biden says 100 million US vaccines target will be met this week

Pakistan is among the countries currently experiencing the third wave where day by day, the number of patients is constantly increasing. According to a report published in the British newspaper Daily Mail, patients suffering from Corona virus are better off if they take an aspirin pill. Even if a patient is severely affected by the virus, they can be saved from a visit to the ICU.

Finland’s Johanna Nordblad claims under-ice freedive record

No easy fixes as US, China diplomats meet in Alaska

The researchers explained that taking an aspirin pill on a daily basis can reduce the patients chances of a visit to the ICU exponentially, as low as 40%.

The team, led by George Washington University School of Medicine in the District of Columbia, says the findings show that patients can be treated faster, easier and cheaper than commonly used medications.

French PM Announces Limited COVID Lockdown for Paris

Barcelona Taxi Drivers Protest Against Uber’s Return

“We started administering aspirin to patients, because many of them had multiple complications, or blood clots were forming in their bodies. That’s why we thought anti-platelet agents, or aspirin, diluted the blood,” Dr. Jonathan Chow, an assistant professor at the George Washington School of Medicine and Health Sciences, told CNN.

11 bullet-ridden bodies found in eastern Libya

World Bank rolls out vaccine funds for impoverished Asian nations

NASA testing giant rocket for next Moon mission

Nasdaq drops 3% on inflation fears, WTI oil loses 7.1%

Intensity in new wave of patients across Pakistan, how many have recovered?

Stay tuned to Baaghi TV for the latest news and updates!

Leave A Reply

Your email address will not be published.